3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lymphoma
3
Glioblastoma
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Small Cell Lung Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Gliosarcoma
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Interventions
ibrutinib
4
fludarabine phosphate
4
fludarabine
4
Rituximab
4
Bendamustine Hydrochloride
3
blinatumomab
2
Melphalan
2
Lenalidomide
2
Cyclophosphamide
2
Busulfan
2
Alemtuzumab
2
thymoglobulin
1
sargramostim
1
pirtobrutinib
1
pegaspargase
1
palbociclib
1
ofatumumab
1
obinutuzumab
1
lirilumab
1
copanlisib
1
Vincristine
1
RFT5-SMPT-dgA immunotoxin
1
Prednisone
1
Prednisolone
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Leukapheresis
1
Immunotherapy, Adoptive
1
Hydrocortisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Lymphoid
×
enzastaurin
×
Clear all
No trials found.